For pure weight-loss endpoints, retatrutide outperforms semaglutide by roughly 9 percentage points at peak dose: 24.2% versus ~15% mean body-weight loss at comparable durations [3][4]
5mg vial dose charts 5mg vial + 1mL bacteriostatic water = 5mg/mL At this concentration, a 5mg vial gives you five weeks of coverage at the 1mg initiation dose, or just over two weeks at 2mg
And this nutritional depletion increases the risk of many other chronic inflammatory diseases
however, since healthcare providers sometimes prescribe Mounjaro and Ozempic off-label for weight loss in people without type 2 diabetes, studies comparing tirzepatide and semaglutide in people with overweight and obesity are also important
According to UK product information, all three sites are acceptable, and no dose adjustment is required based on injection site
New England Journal of Medicine 391, 15731583 (2024)